WallStreetZenWallStreetZen

NASDAQ: DNLI
Denali Therapeutics Inc Stock Ownership - Who owns Denali Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Denali Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve E. KrognesDirector2025-01-073,339$20.81
$69.48kSell
Ryan J. WattsPresident and CEO2025-01-077,650$20.81
$159.20kSell
Carole HoChief Medical Officer2025-01-072,907$20.81
$60.49kSell
Alexander O. SchuthCOFO and Secretary2025-01-072,907$20.81
$60.49kSell
Alexander O. SchuthCOFO and Secretary2025-01-0612,255$20.22
$247.80kSell
Carole HoChief Medical Officer2025-01-0612,255$20.22
$247.80kSell
Ryan J. WattsPresident and CEO2025-01-0629,266$20.22
$591.76kSell
Vicki L. SatoDirector2025-01-023,080$20.91
$64.40kSell
Steve E. KrognesDirector2024-12-3130,000$20.25
$607.50kSell
Alexander O. SchuthCOFO and Secretary2024-12-276,708$5.28
$35.42kBuy

1 of 5

DNLI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DNLI insiders and whales buy or sell their stock.

DNLI Shareholders

What type of owners hold Denali Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen14.28%20,749,930$292.57MInsider
Blackrock Inc9.52%13,834,956$195.07MInstitution
Biogen Inc9.16%13,310,243$187.67MInsider
Baillie Gifford Co8.32%12,090,040$170.47MInstitution
Vanguard Group Inc8.12%11,799,757$166.38MInstitution
Wellington Management Group LLP7.85%11,409,598$160.88MInstitution
Arch Venture Fund VIII LP7.34%10,668,749$150.43MInsider
Douglas K. Bratton6.94%10,084,938$142.20MInsider
Fmr LLC6.73%9,779,988$137.90MInsider
Flagship Ventures Fund V LP6.14%8,918,749$125.75MInsider

1 of 3

DNLI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DNLI60.00%40.00%Net Selling
KNSA54.78%9.64%Net SellingNet Selling
RXRX74.85%17.18%Net SellingNet Selling
NAMS73.20%26.80%Net SellingNet Buying
VCEL91.20%8.80%Net SellingNet Buying
View Top Biotech Stocks

Denali Therapeutics Stock Ownership FAQ

Who owns Denali Therapeutics?

Denali Therapeutics (NASDAQ: DNLI) is owned by 91.46% institutional shareholders, 60.98% Denali Therapeutics insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Denali Therapeutics shareholder, owning 20.75M shares representing 14.28% of the company. Robert Nelsen's Denali Therapeutics shares are currently valued at $292.57M.

If you're new to stock investing, here's how to buy Denali Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.